| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 172 | 2022 |
| Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention NF Lange, P Radu, JF Dufour Journal of hepatology 75 (5), 1217-1227, 2021 | 74 | 2021 |
| PPAR-targeted therapies in the treatment of non-alcoholic fatty liver disease in diabetic patients NF Lange, V Graf, C Caussy, JF Dufour International journal of molecular sciences 23 (8), 4305, 2022 | 38 | 2022 |
| A global research priority agenda to advance public health responses to fatty liver disease JV Lazarus, HE Mark, AM Allen, JP Arab, P Carrieri, M Noureddin, ... Journal of hepatology 79 (3), 618-634, 2023 | 34 | 2023 |
| Changing epidemiology of HCC: how to screen and identify patients at risk? N Lange, JF Dufour Digestive diseases and sciences 64, 903-909, 2019 | 27 | 2019 |
| High subcutaneous adipose tissue density correlates negatively with survival in patients with hepatocellular carcinoma L von Hessen, M Roumet, MH Maurer, N Lange, H Reeves, JF Dufour, ... Liver International 41 (4), 828-836, 2021 | 24 | 2021 |
| Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two‐dimensional shear wave elastography in non‐alcoholic fatty … YP Mendoza, SG Rodrigues, MG Delgado, G Murgia, NF Lange, ... Liver international 42 (1), 102-111, 2022 | 17 | 2022 |
| Non-invasive tools for compensated advanced chronic liver disease and portal hypertension after Baveno VII–an update D Segna, YP Mendoza, NF Lange, SG Rodrigues, A Berzigotti Digestive and Liver Disease 55 (3), 326-335, 2023 | 14 | 2023 |
| Anticoagulation quality and clinical outcomes in multimorbid elderly patients with acute venous thromboembolism N Lange, M Méan, O Stalder, A Limacher, T Tritschler, N Rodondi, ... Thrombosis research 177, 10-16, 2019 | 13 | 2019 |
| Endoplasmic reticulum and mitochondria contacts correlate with the presence and severity of NASH in humans C Jin, E Felli, NF Lange, A Berzigotti, J Gracia-Sancho, JF Dufour International journal of molecular sciences 23 (15), 8348, 2022 | 9 | 2022 |
| Validation of the blood test MACK-3 for the noninvasive diagnosis of fibrotic nonalcoholic steatohepatitis: an international study with 1924 patients CM Canivet, MH Zheng, S Qadri, L Vonghia, KH Chuah, C Costentin, ... Clinical Gastroenterology and Hepatology 21 (12), 3097-3106. e10, 2023 | 4 | 2023 |
| 2D shear wave elastography of the rectus femoris muscle in patients with cirrhosis: Feasibility and clinical findings. A pilot study C Becchetti, NF Lange, MG Delgado, MP Brönnimann, MH Maurer, ... Clinics and research in hepatology and gastroenterology 47 (3), 102080, 2023 | 4 | 2023 |
| Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study H Zhang, RS Rios, J Boursier, R Anty, WK Chan, J George, Y Yilmaz, ... Chinese medical journal 136 (03), 341-350, 2023 | 3 | 2023 |
| Dietary interventions in liver diseases: focus on MAFLD and cirrhosis É Vuille-Lessard, N Lange, C Riebensahm, JF Dufour, A Berzigotti Current Hepatology Reports 20, 61-76, 2021 | 3 | 2021 |
| Risk of liver-related events in metabolic dysfunction–associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria G Pennisi, M Enea, M Romero-Gomez, E Bugianesi, VWS Wong, ... Hepatology 79 (4), 912-925, 2024 | 2 | 2024 |
| Interleaved trinuclear MRS for single‐session investigation of carbohydrate and lipid metabolism in human liver at 7T S Poli, AF Emara, NF Lange, E Ballabani, A Buser, M Schiavon, D Herzig, ... NMR in Biomedicine, e5123, 2024 | 1 | 2024 |
| Body composition parameters predict outcomes of acute kidney injury in patients with cirrhosis NF Lange, JF Dufour, A Berzigotti, S Gomes Rodrigues Journal of hepatology 73 (Suppl. 1), S746-S746, 2020 | 1 | 2020 |
| 254-LB: In Vivo Mapping of Postprandial Hepatic Glucose Metabolism Using Stable Isotope-Assisted Metabolic Imaging in Roux-en-Y Gastric Bypass Adults and Nonoperated Controls NF Lange, S Poli, D Herzig, M Schiavon, C DALLA MAN, R Kreis, L Bally Diabetes 72 (Supplement_1), 2023 | | 2023 |
| Standardized non-invasive screening for non-alcoholic fatty liver disease in people with type 2 diabetes identifies a substantial number of individuals with advanced liver disease N Lange, J Schropp, M Hilpert, A Melmer, M Laimer, C Stettler, ... Journal of Hepatology 78, S664, 2023 | | 2023 |
| What patients with nonalcoholic fatty liver disease should we treat with pharmacological agents? G Pennisi, M Enea, M Romero-Gomez, E Bugianesi, VWS Wong, ... | | 2023 |
